TEVA logo

TEVA
Teva- Pharmaceutical Industries Ltd. - ADR

26,914
Mkt Cap
$40.7B
Volume
6.63M
52W High
$37.35
52W Low
$14.99
PE Ratio
25.97
TEVA Fundamentals
Price
$34.95
Prev Close
$35.07
Open
$35.16
50D MA
$31.25
Beta
0.81
Avg. Volume
6.07M
EPS (Annual)
$1.22
P/B
4.94
Rev/Employee
$523,613.72
$49,934.02
Loading...
Loading...
News
all
press releases
Wall Street Zen Downgrades Teva Pharmaceutical Industries (NYSE:TEVA) to Hold
Wall Street Zen lowered Teva Pharmaceutical Industries from a 'strong-buy' rating to a 'hold' rating in a report on Saturday...
MarketBeat·8h ago
News Placeholder
More News
News Placeholder
75,000 Shares in Teva Pharmaceutical Industries Ltd. $TEVA Purchased by Nkcfo LLC
Nkcfo LLC acquired a new position in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·1d ago
News Placeholder
Jennison Associates LLC Invests $47.86 Million in Teva Pharmaceutical Industries Ltd. $TEVA
Jennison Associates LLC bought a new stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·1d ago
News Placeholder
Teva Pharmaceutical Industries (NYSE:TEVA) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
JPMorgan Chase & Co. increased their price objective on shares of Teva Pharmaceutical Industries from $35.00 to $40.00 and gave the stock an "overweight" rating in a report on Thursday...
MarketBeat·2d ago
News Placeholder
UBS Group Issues Positive Forecast for Teva Pharmaceutical Industries (NYSE:TEVA) Stock Price
UBS Group raised their target price on shares of Teva Pharmaceutical Industries from $36.00 to $42.00 and gave the company a "buy" rating in a report on Thursday...
MarketBeat·2d ago
News Placeholder
Teva Pharmaceutical Industries' (TEVA) Overweight Rating Reiterated at Piper Sandler
Piper Sandler reiterated an "overweight" rating and set a $42.00 price target (up from $41.00) on shares of Teva Pharmaceutical Industries in a research report on Thursday...
MarketBeat·2d ago
News Placeholder
Truist Financial Increases Teva Pharmaceutical Industries (NYSE:TEVA) Price Target to $45.00
Truist Financial boosted their target price on Teva Pharmaceutical Industries from $42.00 to $45.00 and gave the company a "buy" rating in a research note on Thursday...
MarketBeat·2d ago
News Placeholder
TEVA Q1 Earnings Top Estimates, Branded Drugs Drive Revenues, Stock Up
Teva beats Q1 earnings and revenue estimates as Austedo, Ajovy and Uzedy fuel growth, lifting shares despite weaker generics performance.
Zacks·2d ago
News Placeholder
Promising Pharmaceutical Stocks To Research - April 29th
Eli Lilly and Company, KalVista Pharmaceuticals, AbbVie, Regeneron Pharmaceuticals, and Teva Pharmaceutical Industries are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, devel...
MarketBeat·3d ago
News Placeholder
Teva Pharmaceutical Industries (NYSE:TEVA) Announces Quarterly Earnings Results
Teva Pharmaceutical Industries (NYSE:TEVA - Get Free Report) posted its quarterly earnings data on Wednesday. The company reported $0.53 earnings per share for the quarter, topping the consensus...
MarketBeat·3d ago
<
1
2
...
>

Latest TEVA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.